These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 26885215
21. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis. Feng YQ, Li YU, Xiao WD, Wang GX, Li YO. Genet Mol Res; 2015 Oct 28; 14(4):13391-402. PubMed ID: 26535654 [Abstract] [Full Text] [Related]
23. MTHFR C677T polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls. He L, Shen Y. Onco Targets Ther; 2017 Oct 28; 10():227-238. PubMed ID: 28123304 [Abstract] [Full Text] [Related]
24. Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk. Yuan C, Liu X, Li R, Yan S, Kong B. Arch Med Sci; 2020 Oct 28; 16(3):682-691. PubMed ID: 32399118 [Abstract] [Full Text] [Related]
25. Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis. Kamali M, Hamadani S, Neamatzadeh H, Mazaheri M, Zare Shehneh M, Modaress Gilani M, Haghighi F. Asian Pac J Cancer Prev; 2017 Jul 27; 18(7):1743-1749. PubMed ID: 28749098 [Abstract] [Full Text] [Related]
27. Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis. Li C, Liu Y, Hu Z, Zhou Y. Leuk Lymphoma; 2014 Jun 27; 55(6):1309-19. PubMed ID: 23978154 [Abstract] [Full Text] [Related]
29. RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population. Jara L, Acevedo ML, Blanco R, Castro VG, Bravo T, Gómez F, Waugh E, Peralta O, Cabrera E, Reyes JM, Ampuero S, González-Hormazábal P. Cancer Genet Cytogenet; 2007 Oct 01; 178(1):65-9. PubMed ID: 17889711 [Abstract] [Full Text] [Related]
31. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis. Zhang K, Zhang L, Zhou J, Hao Z, Fan S, Yang C, Liang C. Onco Targets Ther; 2016 Oct 01; 9():567-77. PubMed ID: 26869801 [Abstract] [Full Text] [Related]
32. Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis. Xu T, Zhang S, Qiu D, Li X, Fan Y. Gene; 2020 Oct 30; 759():144972. PubMed ID: 32739585 [Abstract] [Full Text] [Related]
35. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls. Gu Y, Shi J, Qiu S, Qiao Y, Zhang X, Cheng Y, Liu Y. BMC Cancer; 2018 Nov 01; 18(1):1060. PubMed ID: 30384829 [Abstract] [Full Text] [Related]
38. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis. Irshad M, Mandal RK, Al-Drees A, Khalil MS, Abdulghani HM. Asian Pac J Cancer Prev; 2015 Nov 01; 16(14):5663-7. PubMed ID: 26320432 [Abstract] [Full Text] [Related]
39. The association of ADAM12 polymorphism with osteoarthritis susceptibility: a meta-analysis. Wu Z, Xu XW, Zhang XW. Ther Clin Risk Manag; 2017 Nov 01; 13():821-830. PubMed ID: 28721062 [Abstract] [Full Text] [Related]
40. mEH Tyr113His polymorphism and the risk of ovarian cancer development. Zhong JH, Zhang ZM, Li LQ. J Ovarian Res; 2013 Jun 06; 6(1):40. PubMed ID: 23742121 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]